Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IMPAIRED FUNCTION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 136 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gomez, F; Ruiz, P; Bernal, A; Escobar, M; Garcia-Egido, A; Lopez-Saez, JJB
      Enhancement of splenic-macrophage Fc gamma receptor expression by treatment with estrogens

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    2. Trejo, YG; Bordenave, RH; Beviacqua, M; Rumi, LS
      In vitro secretion of cytokines and prostaglandin-E-2 by monocytes from lung cancer patients

      RESPIRATORY MEDICINE
    3. Aminimanizani, A; Beringer, P; Jelliffe, R
      Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials

      CLINICAL PHARMACOKINETICS
    4. Izzedine, H; Launay-Vacher, V; Baumelou, A; Deray, G
      An appraisal of antiretroviral drugs in hemodialysis

      KIDNEY INTERNATIONAL
    5. Mayer, AS; Newman, LS
      Genetic and environmental modulation of chronic obstructive pulmonary disease

      RESPIRATION PHYSIOLOGY
    6. Doggrell, SA
      Is ramipril the pril for diabetes and kidney disease?

      DRUGS OF TODAY
    7. Hinderling, PH
      Biased estimates of nonrenal clearance

      JOURNAL OF PHARMACEUTICAL SCIENCES
    8. Anderson, RA; Jones, CJH; Goodfellow, J
      Is the fatty meal a trigger for acute coronary syndromes

      ATHEROSCLEROSIS
    9. Belz, GG; Breithaupt-Grogler, K; Osowski, U
      Treatment of congestive heart failure - current status of use of digitoxin

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    10. Perlini, S; Muiesan, ML; Cuspidi, C; Sampieri, L; Trimarco, B; Aurigemma, GP; Agabiti-Rosei, E; Mancia, G
      Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry

      CIRCULATION
    11. Boisdron-Celle, N; Lebouil, A; Allain, P; Gamelin, E
      Pharmacokinetic properties of platinium derivatives

      BULLETIN DU CANCER
    12. Wright, JG; Boddy, AV; Highley, M; Fenwick, J; McGill, A; Calvert, AH
      Estimation of glomerular filtration rate in cancer patients

      BRITISH JOURNAL OF CANCER
    13. Chen, G; Shankar, P; Lange, C; Valdez, H; Skolnik, PR; Wu, LJ; Manjunath, N; Lieberman, J
      CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus,and cytomegalovirus lack molecules for homing to lymphoid sites of infection

      BLOOD
    14. van Rijswijk, REN; Vermorken, JB
      Drug therapy for gynaecological cancer in older women

      DRUGS & AGING
    15. Collins, JM
      Cytochrome P-450 and other determinants of pharmacokinetics, toxicity, andefficacy in humans

      CLINICAL CANCER RESEARCH
    16. Gomez, F; Ruiz, P; Lopez, R; Rivera, C; Romero, S; Bernal, JA
      Effects of androgen treatment on expression of macrophage Fc gamma receptors

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    17. Nicholls, MG; Robertson, JIS
      The renin-angiotensin system in the year 2000

      JOURNAL OF HUMAN HYPERTENSION
    18. Mochizuki, Y; Oishi, M; Takasu, T
      Effects of bunazosin hydrochloride sustained-release formulation on cerebral circulation

      INTERNATIONAL ANGIOLOGY
    19. Coll, E; Botey, A; Alvarez, L; Poch, E; Quinto, L; Saurina, A; Vera, M; Piera, C; Darnell, A
      Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment

      AMERICAN JOURNAL OF KIDNEY DISEASES
    20. Poschel, KA; Bucha, E; Esslinger, HU; Nortersheuser, P; Jansa, U; Schindler, S; Nowak, G; Stein, G
      Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure

      KIDNEY INTERNATIONAL
    21. Domanovits, H; Mullner, M; Sterz, F; Schillinger, M; Klosch, C; Paulis, M; Hirschl, MM; Laggner, AN
      Impairment of renal function in patients resuscitated from cardiac arrest:frequency, determinants and impact on outcome

      WIENER KLINISCHE WOCHENSCHRIFT
    22. Sterner, G; Frennby, B; Kurkus, J; Nyman, U
      Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy?

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    23. Fukae, H; Kinoshita, H; Fujimoto, S; Nakazato, M; Eto, T
      Plasma concentration of uroguanylin in patients on maintenance dialysis therapy

      NEPHRON
    24. Zwissler, B
      Impaired right ventricular function

      ANAESTHESIST
    25. Gomez, F; Ruiz, P; Briceno, F; Rivera, C; Lopez, R
      Macrophage Fc gamma receptors expression is altered by treatment with dopaminergic drugs

      CLINICAL IMMUNOLOGY
    26. Silverman, KC; Nanmann, BD; Holder, DJ; Dixit, R; Faria, EC; Sargent, EV; Gallo, MA
      Establishing data-derived adjustment factors from published pharmaceuticalclinical trial data

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    27. Sub, DH; Skowronski, GA; Abdel-Rahman, MS
      The use of kinetic and dynamic data in risk assessment of drugs

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    28. Gouillat, C; Manganas, D; Saguier, G; Duque-Campos, R; Berard, P
      Resection of hepatocellular carcinoma in cirrhotic patients: Longterm results of a prospective study

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    29. Iwamoto, M; Hiroshige, K; Suda, T; Ohta, T; Ohtani, A; Nakashima, Y
      Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis

      PERITONEAL DIALYSIS INTERNATIONAL
    30. Mirza, BI; Sahani, M; Leehey, DJ; Patel, SB; Yang, VL; Ing, TS
      Saline-induced dilutional acidosis in a maintenance hemodialysis patient

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    31. Sheridan, DJ; Kingsbury, MP; Flores, NA
      Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    32. Barnard, EJ; Venter, KF
      Antidepressant therapy in high-risk patients

      SOUTH AFRICAN MEDICAL JOURNAL
    33. Wu, CC; Ho, WL; Lin, MC; Tang, JS; Yeh, DC; Liu, TJ; P'eng, FK
      Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?

      HEPATO-GASTROENTEROLOGY
    34. MacFarlane, GD; Shaw, LM; Venkataramanan, R; Mullins, R; Scheller, DG; Ersfeld, DL
      Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function

      THERAPEUTIC DRUG MONITORING
    35. Al-Rashood, KA; Al-Khamis, KI; El-Sayed, YM; Al-Bella, S; Al-Yamani, MA; Alam, SM; Dham, R
      Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax((R)) versus Maxaquin((R))) in healthy human volunteers

      BIOPHARMACEUTICS & DRUG DISPOSITION
    36. Mazzei, T; Surrenti, C; Novelli, A; Biagini, MR; Fallani, S; Cassetta, MI; Conti, S; Surrenti, E
      Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Prescott, E; Vestbo, J
      Socioeconomic status and chronic obstructive pulmonary disease

      THORAX
    38. Worgall, S; Bezdicek, P; Kim, MK; Park, JG; Singh, R; Christofidou-Solomidou, M; Prince, A; Kovesdi, I; Schreiber, AD; Crystal, RG
      Augmentation of pulmonary host defense against Pseudomonas by Fc gamma RIIA cDNA transfer to the respiratory epithelium

      JOURNAL OF CLINICAL INVESTIGATION
    39. Bezdicek, P; Worgall, S; Kovesdi, I; Kim, MK; Park, JG; Vincent, T; Leopold, PL; Schreiber, AD; Crystal, RG
      Enhanced liver uptake of opsonized red blood cells after in vivo transfer of Fc gamma RIIA cDNA to the liver

      BLOOD
    40. CHENG IKP; FANG GX; WONG MC; JI YL; CHAN KW; YEUNG HWD
      A RANDOMIZED PROSPECTIVE COMPARISON OF NADOLOL, CAPTOPRIL WITH OR WITHOUT TICLOPIDINE ON DISEASE PROGRESSION IN IGA NEPHROPATHY

      Nephrology
    41. MONTENEGRO LM; WARD A; MCGOWAN FX; DAVIS PJ
      NEW DIRECTIONS IN PERIOPERATIVE MANAGEMENT FOR PEDIATRIC SOLID-ORGAN TRANSPLANTATION

      Journal of cardiothoracic and vascular anesthesia
    42. Matthis, C; Weber, U; O'Neill, TW; Raspe, H
      Health impact associated with vertebral deformities: Results from the European vertebral osteoporosis study (EVOS)

      OSTEOPOROSIS INTERNATIONAL
    43. EGORIN MJ
      OVERVIEW OF RECENT TOPICS IN CLINICAL-PHARMACOLOGY OF ANTICANCER AGENTS

      Cancer chemotherapy and pharmacology
    44. WIEST D; KLEE W
      RETROSPECTIVE ANALYSIS OF SERUM UREA AND CREATININE IN DIARRHEIC CALVES

      DTW. Deutsche tierarztliche Wochenschrift
    45. KIRSTEN R; NELSON K; KIRSTEN D; HEINTZ B
      CLINICAL PHARMACOKINETICS OF VASODILATORS - PART 1

      Clinical pharmacokinetics
    46. CACCIA S
      METABOLISM OF THE NEWER ANTIDEPRESSANTS - AN OVERVIEW OF THE PHARMACOLOGICAL AND PHARMACOKINETIC IMPLICATIONS

      Clinical pharmacokinetics
    47. POWER BM; FORBES AM; VANHEERDEN PV; ILETT KF
      PHARMACOKINETICS OF DRUGS USED IN CRITICALLY ILL ADULTS

      Clinical pharmacokinetics
    48. de Lemos, ML
      Application of the area under the curve of carboplatin in predicting toxicity and efficacy

      CANCER TREATMENT REVIEWS
    49. MCAINSH AM; GEYER M; FANDREY J; RUEGG JC; WIESNER RJ
      EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR DURING THE DEVELOPMENT OF CARDIAC-HYPERTROPHY IN SPONTANEOUSLY HYPERTENSIVE RATS

      Molecular and cellular biochemistry
    50. MAUGERI FS; CAMPANA M; FERRARI R; GIORDANO A; SCALVINI S; VOLTERRANI M; BERNARDI L; CALCIATI A; FINARDI G; PERLINI S; RADAELLI A; SOLDA PL; ADAMOPOULOS S; COATS AJS; CHUA TP; PIEPOLI M; POOLEWILSON PA; PONIKOWSKI P; VOLTERRANI M; WEBBPEPLOE K; BARLOW C; CONWAY J; DAVEY PP; MEYER TE; PATERSON DJ; ROBBINS P; SLEIGHT P; KARA T; SOUCE M; SPINAROVA L; STEJFA M; TOMAN J; ZATLOUKAL B; SZELEMERY R; WRABEC K
      EXPERIENCE FROM CONTROLLED TRIALS OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE - PROTOCOL AND PATIENT FACTORS IN EFFECTIVENESS IN THE IMPROVEMENT IN EXERCISE TOLERANCE

      European heart journal
    51. GONZALEZ E; RIMOLA A; NAVASA M; ANDREU H; GRANDE L; GARCIAVALDECASAS JC; CIRERA I; VISA J; RODES J
      LIVER-TRANSPLANTATION IN PATIENTS WITH NON-BILIARY CIRRHOSIS - PROGNOSTIC VALUE OF PREOPERATIVE FACTORS

      Journal of hepatology
    52. PEREIRA BJG; NATOV SN; BOUTHOT BA; MURTHY BVR; RUTHAZER R; SCHMID CH; LEVEY AS
      EFFECT OF HEPATITIS-C INFECTION AND RENAL-TRANSPLANTATION ON SURVIVALIN END-STAGE RENAL-DISEASE

      Kidney international
    53. NATALE RB
      EXPERIENCE WITH NEW CHEMOTHERAPEUTIC-AGENTS IN NONSMALL CELL LUNG-CANCER

      Chest
    54. LEVEQUE D; GALLIONRENAULT C; MONTEIL H; JEHL F
      ANALYSIS OF RECENT ANTIMICROBIAL AGENTS IN HUMAN BIOLOGICAL-FLUIDS BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography
    55. RUDORFER MV; POTTER WZ
      THE ROLE OF METABOLITES OF ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSION

      CNS DRUGS
    56. LANGTRY HD; MARKHAM A
      LISINOPRIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN ELDERLY PATIENTS

      Drugs & aging
    57. CERULLI J; GAILEY RA; LOW CL; BAILIE GR
      EFFECT OF INTERMITTENT HEMODIALYSIS ON NONDEPOLARIZING SKELETAL-MUSCLE RELAXANTS

      The Annals of pharmacotherapy
    58. ANDO Y; MINAMI H; SAKA H; ANDO M; SUGIURA S; SAKAI S; SHIMOKATA K
      PHARMACOKINETIC STUDY OF CARBOPLATIN GIVEN ON A 5-DAY INTRAVENOUS SCHEDULE

      Japanese journal of cancer research
    59. JOHANSEN MJ; MADDEN T; MEHRA RC; WOOD JG; RONDON G; BROWNE V; NEWMAN RA; CHAMPLIN RE
      PHASE-I PHARMACOKINETIC STUDY OF MULTICYCLE HIGH-DOSE CARBOPLATIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH CANCER

      Journal of clinical oncology
    60. ELKHAILI H; POMPEI D; PETER JD; LINGER L; SALMON J; LEVEQUE D; NIEDERGANG S; SALMON Y; THIERRY RC; MONTEIL H; JEHL F
      IN-VIVO PHARMACOKINETIC OF AMIKACIN AND I TS PHARMACODYNAMIC IN COMBINATION WITH CEFEPIME, CEFPIROME AND MEROPENEM IN AN IN-VITRO EX-VIVO MICROPIG MODEL

      Pathologie et biologie
    61. GUILLET P; MONJANEL S; NICOARA A; DUFFAUD F; LACARELLE B; BAGARRYLIEGEY D; DURAND A; CATALIN J; FAVRE R
      A BAYESIAN DOSING METHOD FOR CARBOPLATIN GIVEN BY CONTINUOUS-INFUSIONFOR 120 H

      Cancer chemotherapy and pharmacology
    62. DUFFULL SB; ROBINSON BA
      CLINICAL PHARMACOKINETICS AND DOSE OPTIMIZATION OF CARBOPLATIN

      Clinical pharmacokinetics
    63. TIAN S; KUSANO E; OHARA T; TABEI K; ITOH Y; KAWAI T; ASANO Y
      CYSTATIN-C MEASUREMENT AND ITS PRACTICAL USE IN PATIENTS WITH VARIOUSRENAL DISEASES

      Clinical nephrology
    64. SCHMIEDER RE; SCHOBEL HP; GATZKA C; LANGENFELD M; SCHLEBUSCH H
      EFFECTS OF ANTIHYPERTENSIVE THERAPY ON EA RLY TARGET ORGAN DAMAGE - COMPARISON OF ALPHA-BLOCKER VERSUS BETA-BLOCKER

      Nieren- und Hochdruckkrankheiten
    65. GABRIEL H; ROTHE G; KORPYS M; SCHMITZ G; KINDERMANN W
      ENHANCED EXPRESSION OF HLA-DR, FC-GAMMA RECEPTOR-1 (CD64) AND LEUKOCYTE COMMON ANTIGEN (CD45) INDICATE ACTIVATION OF MONOCYTES IN REGENERATIVE TRAINING PERIODS OF ENDURANCE ATHLETES

      International journal of sports medicine
    66. WONG SF; LEUNG MP; CHAN MY
      PHARMACOKINETICS OF FLUCONAZOLE IN CHILDREN REQUIRING PERITONEAL-DIALYSIS

      Clinical therapeutics
    67. MANI S; RATAIN MJ
      NEW PHASE-I TRIAL METHODOLOGY

      Seminars in oncology
    68. SMITH RET; NIEWIESK S; BOOTH S; BANGHAM CRM; DAENKE S
      FUNCTIONAL CONSERVATION OF HTLV-1 REX BALANCES THE IMMUNE PRESSURE FOR SEQUENCE VARIATION IN THE REX GENE

      Virology
    69. PARODI O; PALOMBO C; SAMBUCETI G; GIORGETTI A; MARABOTTI C; GALLOPIN M; SIMONETTI I; LABBATE A
      COMPARATIVE EFFECTS OF ENALAPRIL AND VERAPAMIL ON MYOCARDIAL BLOOD-FLOW IN SYSTEMIC HYPERTENSION

      Circulation
    70. BENEZET S; CHATELUT E; BAGHERI H; RIGALHUGUET F; NGUYEN L; POURRAT J; ROBERT A; MONTASTRUC JL; CANAL P
      INEFFICACY OF EXCHANGE-TRANSFUSION IN A METHOTREXATE INTOXICATION

      Bulletin du cancer
    71. SCHIFF DE; RAE J; MARTIN TR; DAVIS BH; CURNUTTE JT
      INCREASED PHAGOCYTE FC-GAMMA-RI EXPRESSION AND IMPROVED FC-GAMMA-RECEPTOR-MEDIATED PHAGOCYTOSIS AFTER IN-VIVO RECOMBINANT HUMAN INTERFERON-GAMMA TREATMENT OF NORMAL HUMAN-SUBJECTS

      Blood
    72. KOEPPE P; HOFFLER D; FITZEN B
      BIAPENEM PHARMACOKINETICS IN HEALTHY-VOLUNTEERS AND IN PATIENTS WITH IMPAIRED RENAL-FUNCTION

      Arzneimittel-Forschung
    73. VALLE M; ESTEBAN M; RODRIGUEZSASIAIN JM; CALVO R; AGUIRRE C
      CHARACTERISTICS OF SERUM-PROTEIN BINDING OF FELODIPINE

      Research communications in molecular pathology and pharmacology
    74. VROOM MB; VANWEZEL HB; VANDERBRINK RBA; VANDERLEE R; EIJSMAN L; VISSER CA; VANZWIETEN PA
      EFFECTS OF DOBUTAMINE AND ENOXIMONE ON TRANSMITRAL AND PULMONARY VENOUS FLOW CHARACTERISTICS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER CORONARY-ARTERY BYPASS-GRAFTING

      Journal of cardiothoracic and vascular anesthesia
    75. CHATTERJEE M; MAJUMDER A; IYER P; MUTHUKRISHNAN G; DAS MK; RAMAMOORTHY N; DESAI CN; BANERJEE S
      ANOMALIES IN HEPATOBILIARY EXCRETION OF TECHNETIUM-99M-MAG(3) PREPARATIONS

      Nuclear medicine and biology
    76. ABIKO T; SEKINO H
      SYNTHESES OF 2 DEACETYL-THYMOSIN ALPHA(1) ANALOGS AND THEIR EFFECTS ON LOW E-ROSETTE-FORMING LYMPHOCYTES OF UREMIC PATIENTS

      Mediators of inflammation
    77. LYNCH AM; KAPILA R
      OVERWHELMING POSTSPLENECTOMY INFECTION

      Infectious disease clinics of North America
    78. ATAGI S; FURUSE K; KAWAHARA M; KODAMA N; OGAWARA M; KUBOTA K; MATSUI K; KUSUNOKI Y; MASUDA N; TAKADA M; NEGORO S; FUKUOKA M
      DOSE-ESCALATION STUDY OF ORAL ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH ADVANCED LUNG-CANCER

      Japanese Journal of Clinical Oncology
    79. GHAZALASWAD S; CALVERT AH; NEWELL DR
      A SINGLE-SAMPLE ASSAY FOR THE ESTIMATION OF THE AREA UNDER THE FREE CARBOPLATIN PLASMA-CONCENTRATION VERSUS TIME CURVE

      Cancer chemotherapy and pharmacology
    80. BALD M; LETTGEN B; WINGEN AM; BONZEL KE
      24-HOUR BLOOD-PRESSURE MONITORING IN CHILDREN AND ADOLESCENTS AFTER RECOVERY FROM HEMOLYTIC-UREMIC SYNDROME

      Clinical nephrology
    81. DESOIZE B; DUFOUR R; URIEN S; KALTENBACH M; COLIN P
      EVALUATION OF 2 DOSE INDIVIDUALIZATION METHODS FOR CARBOPLATIN

      Anticancer research
    82. YANAGAWA H; TAKISHITA Y; BANDO H; SUMITANI H; OKADA S
      CARBOPLATIN-BASED CHEMOTHERAPY IN PATIENTS UNDERGOING HEMODIALYSIS

      Anticancer research
    83. STYRT BA; PIAZZAHEPP TD; CHIKAMI GK
      CLINICAL TOXICITY OF ANTIRETROVIRAL NUCLEOSIDE ANALOGS

      Antiviral research
    84. TAKAHASHI N; SUZUKI T; TAKAHASHI J; SATOH M; SATOH A; SAITOH H; FUNYU T
      CLINICAL-EVALUATION OF FACTOR-ANALYSIS BY DYNAMIC-SPECT FOR TRANSPLANTED KIDNEYS

      Transplantation proceedings
    85. TOKUS M; SUSAL C; FILSER T; STAEDT U; OPELZ G
      ANTI-F(AB')(2) AUTOANTIBODIES IN PATIENTS WITH LIVER-CIRRHOSIS

      Die medizinische Welt
    86. GARTY BZ; DOUGLAS SD; DANON YL
      IMMUNE-DEFICIENCY IN GLYCOGEN-STORAGE-DISEASE TYPE 1B

      Israel journal of medical sciences
    87. HELLRIEGEL ET; BJORNSSON TD; HAUCK WW
      INTERPATIENT VARIABILITY IN BIOAVAILABILITY IS RELATED TO THE EXTENT OF ABSORPTION - IMPLICATIONS FOR BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES

      Clinical pharmacology and therapeutics
    88. LIEBL R; KRAMER BK
      COMPLICATIONS AFTER ADMINISTRATION OF CON TRAST-MEDIUM IN HIGH-RISK PATIENTS - IS PROPHYLACTIC DIALYSIS REASONABLE

      Deutsche Medizinische Wochenschrift
    89. SEYFERT UT; FEINDT P; STEIN S; WENZEL E
      DIAGNOSTIC-VALUE OF COAGULATION PARAMETER S FOR CHARACTERIZATION OF ACETYLSALICYLIC ACID-INDUCED PLATELET IMPAIRMENTS

      Infusionstherapie und Transfusionsmedizin
    90. PENG B; BODDY AV; COLE M; PEARSON ADJ; CHATELUT E; RUBIE H; NEWELL DR
      COMPARISON OF METHODS FOR THE ESTIMATION OF CARBOPLATIN PHARMACOKINETICS IN PEDIATRIC CANCER-PATIENTS

      European journal of cancer
    91. LUNDSTROM TS; SOBEL JD
      VANCOMYCIN, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND RIFAMPIN

      Infectious disease clinics of North America
    92. OLVER IN; WEBSTER LK; MILLWARD MJ; STOKES KH; BISHOP JF
      A PHASE-I AND PHARMACOKINETICS STUDY OF PROLONGED AMBULATORY-INFUSIONCARBOPLATIN

      Cancer chemotherapy and pharmacology
    93. ROSCH W; SCHOTT G; KECK M; RUDER H; SCHROTT KM
      DEVELOPMENT OF RENAL-FUNCTION IN CHILDREN WITH FORMER POSTERIOR URETHRAL VALVES

      Der Urologe
    94. CELLA SG; LOCATELLI V; PORATELLI M; COLONNA VD; IMBIMBO BP; DEGHENGHI R; MULLER EE
      HEXARELIN, A POTENT GHRP ANALOG - INTERACTIONS WITH GHRH AND CLONIDINE IN YOUNG AND AGED DOGS

      Peptides
    95. BRANDT BR; ROSEN I
      IMPAIRED PERIPHERAL SOMATOSENSORY FUNCTION IN CHILDREN WITH DOWN-SYNDROME

      Neuropediatrics
    96. HINDERLING PH; SHI JM
      ABSOLUTE BIOAVAILABILITY ESTIMATED FROM ORAL DATA

      Journal of pharmaceutical sciences
    97. KENDALL MJ
      APPROACHES TO MEETING THE CRITERIA FOR FIXED-DOSE ANTIHYPERTENSIVE COMBINATIONS - FOCUS ON METOPROLOL

      Drugs
    98. GIETEMA JA; VELDHUIS GJ; GUCHELAAR HJ; WILLEMSE PHB; UGES DRA; CATS A; BOONSTRA H; VANDERGRAAF WTA; SLEIJFER DT; DEVRIES EGE; MULDER NH
      PHASE-II AND PHARMACOKINETIC STUDY OF LOBAPLATIN IN PATIENTS WITH RELAPSED OVARIAN-CANCER

      British Journal of Cancer
    99. WEIDINGER G
      PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC USE OFBUNAZOSIN IN HYPERTENSION - A REVIEW

      Arzneimittel-Forschung
    100. GUAY DRP
      AMANTADINE AND RIMANTADINE PROPHYLAXIS OF INFLUENZA-A IN NURSING-HOMES - A TOLERABILITY PERSPECTIVE

      Drugs & aging


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 20:02:50